Bispecific antibody fragments with CD20 X CD28 specificity allow effective autologous and allogeneic T-cell activation against malignant cells in peripheral blood and bone marrow cultures from patients with B-cell lineage leukemia and lymphoma.
Bispecific antibody fragments with CD20 X CD28 specificity allow effective autologous and allogeneic T-cell activation against malignant cells in peripheral blood and bone marrow cultures from patients with B-cell lineage leukemia and lymphoma.
复制标题
具有 CD20 X CD28 特异性的双特异性抗体片段可有效激活自体和同种异体 T 细胞,对抗 B 细胞系白血病和淋巴瘤患者外周血和骨髓培养物中的恶性细胞。
作者:
M. Brandl;L. Grosse‐Hovest;E. Holler;H. Kolb;G. Jung
登录
查看更多内容
DOI:
--
发表时间:
1997
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Blazar,BR;Taylor,PA;Boyer,MW;Panoskaltsis-Mortari,A;Allison,JP;Vallera,DA
通讯作者:
Vallera,DA
影响因子:
11.2
作者:
O. Press;A. Farr;Borroz Ki;S. Anderson;P. Martin
通讯作者:
O. Press;A. Farr;Borroz Ki;S. Anderson;P. Martin
影响因子:
4.4
作者:
P. Noel;L. Boise;J. Green;Craig B. Thompson
通讯作者:
P. Noel;L. Boise;J. Green;Craig B. Thompson
DOI:
10.1073/pnas.84.13.4611
发表时间:
1987-07-01
影响因子:
11.1
作者:
JUNG, G;LEDBETTER, JA;MULLEREBERHARD, HJ
通讯作者:
MULLEREBERHARD, HJ
DOI:
10.1073/pnas.92.18.8200
发表时间:
1995-08-29
影响因子:
11.1
作者:
SCHULTZE, JL;CARDOSO, AA;NADLER, LM
通讯作者:
NADLER, LM